Vikram Solar: Strong Volume Momentum, Backward Integration to Drive the Next Margin Cycle

Vikram Solar delivered a strong Q1 FY27 on the volume front, with revenue reaching ₹1,566 Cr, up 88% QoQ and nearly 38% YoY. The company produced 1,085 MW of modules and dispatched 1.06 GW, up nearly 32% YoY, with almost the entire production sold. However, EBITDA margin stood at 8.06%, as the company remained exposed to external cell prices and higher input costs. With the 9 GW cell plant on schedule for first cell release in Q4 FY27, management's focus remains on backward integration and improving margins as captive cell manufacturing comes online.

Volume growth remains strong, supported by healthy module demand

Realizations improved despite a challenging pricing environment

Margin pressure reflects external cell dependence and higher input costs

Cost control below gross margin is already improving

A ₹4,700–5,000 Cr FY27 capex cycle is underway

An ~8 GW order book provides strong volume visibility

DCR business is positioned for faster growth as captive cells come closer

Gangaikodan platform is progressing on schedule

Powerhive adds a new growth leg through BESS

Data centres and green hydrogen could anchor the next decade of demand

ALMM-2 deferment has reopened non-DCR C&I procurement

Automation and value engineering are supporting the cost-reduction programme

Higher-margin customer segments are becoming a bigger focus

Management is holding back FY27 guidance until market visibility improves

Margin recovery is expected as input costs normalise

FY28 could benefit from the ramp-up of the 9 GW cell plant

Outlook

Vikram Solar's Q1 FY27 call points to a business scaling volume while simultaneously building greater manufacturing integration. The near-term environment remains challenging, with external cell dependence, higher input costs, volatile pricing and slower project procurement affecting margins and visibility. At the same time, the company has an ~8 GW order book, 15.5 GW production capability, a 9 GW cell plant on schedule, a 9 GW wafer/ingot plan and a 15 GWh Powerhive roadmap. As captive cell manufacturing comes closer to commissioning, management expects the ability to capture cell manufacturing margins to support a significant improvement in EBITDA margins.

 

Disclaimer - Informational only. Not investment advice.
GoIndia Advisors LLP | SEBI Registered Research Analyst | Reg. No. INH000020040 | BSE Enlistment No. - 6518